528 / 2894
170. Murphy PG, Myers DS, Davies MJ, et al: The
antioxidant potential of propofol (2,6-diisopropyl-
phenol). Br J Anaesth 68:613–618, 1992.
171. Jacobi J, Fraser GL, Coursin DB, et al: Clinical prac-
tice guidelines for the sustained use of sedatives and
analgesics in the critically ill adult. Crit Care Med
30:119–141, 2002.
172. Rudkin GE, Osborne GA, Finn BP, et al: Intra-
operative patient-controlled sedation: Comparison
of patient-controlled propofol with patient-contro-
lled midazolam. Anaesthesia 47:376–381, 1992.
173. Crepeau T, Poincloux L, Bonny C, et al: Significance
of patient-controlled sedation during colonoscopy:
Results from a prospective randomized controlled
study. Gastroenterol Clin Biol 29:1090–1096, 2005.
174. Alhashemi JA,Kaki AM:Anesthesiologist-controlled
versus patient-controlled propofol sedation for shoc-
kwave lithotripsy. Can J Anaesth 53:449–455, 2006.
175. Canessa R, Lema G, Urzua J, et al: Anesthesia for
elective cardioversion: A comparison of four anes-
thetic agents. J Cardiothorac Vasc Anesth 5:566–
568, 1991.
176. Kam PC, Cardone D: Propofol infusion syndrome.
Anaesthesia 62:690–701, 2007.
177. Kang TM: Propofol infusion syndrome in critically
ill patients. Ann Pharmacother 36:1453–1456,
2002.
178. Ahlen K, Buckley CJ, Goodale DB, Pulsford AH:
The «propofol infusion syndrome»: The facts, their
interpretation and implications for patient care. Eur
J Anaesthesiol 23:990–998, 2006.
179. Corssen G, Reves J, Stanley T: Dissociative anesthe-
sia. In: Intravenous Anesthesia and Analgesia. Phi-
ladelphia, Lea & Febiger, 1988, p 99.
180. Halford F: A critique of intravenous anaesthesia in
war surgery. Anaesthesiology 4:67–69, 1943.
181. Mahisekar UL,CallanCM,Derasari M,KirkpatrickAF:
Infusion of large particles of thiopental sodium during
anesthesia induction. J Clin Anesth 6:55–58, 1994.
182. Mark L: Metabolism of barbiturates in man. Clin
Pharmacol Ther 4:504, 1963.
183. Granik S: Induction of the synthesis of d-amino-
levulinic acid synthestase in liver parenchyma cells
in culture by chemicals that induce acute porphyria.
J Biol Chem 238:PC2247, 1963.
184. Bremier D: Pharmacokinetics of methohexitone
following intravenous infusions in humans. Br J
Anaesth 48:643, 1976.
185. Henthorn T, Avram M, Krejcie T: Intravascular
mixing and drug distribution: The concurrent dis-
position of thiopental and indocyanine green. Clin
Pharmacol Ther 45:46, 1989.
186. Christensen J, Andreasen F, Jansen J: Pharmacoki-
netics of thiopentone in a group of young women
and a group of young men. Br J Anaesth 52:913,
1980.
187. Morgan D, Blackman G, Paull J,Wolf L: Pharmaco-
kinetics and plasma binding of thiopental, II:
Studies at cesarean section. Anesthesiology 54:474,
1981.
188. Pandele G, Chaux F, Salvadori C, et al: Thiopental
pharmacokinetics in patients with cirrhosis. Anes-
thesiology 59:123–126, 1983.
189. Toner W, Howard P, McGowan W, Dundee J:
Another look at acute tolerance of thiopentone. Br
J Anaesth 52:1005, 1980.
190. Downie DL, Franks NP, Lieb WR: Effects of thio-
pental and its optical isomers on nicotinic acetyl-
choline receptors. Anesthesiology 93:774–783,
2000.
191. Tomlin SL, Jenkins A, Lieb WR, Franks NP: Prepa-
ration of barbiturate optical isomers and their
effects on GABA(A) receptors. Anesthesiology
90:1714–1722, 1999.
192. Liu H, Yao S: Thiopental sodium reduces glutamate
extracellular levels in rat intact prefrontal cortex.
Exp Brain Res 167:666–669, 2005.
193. Liu H, Dai T, Yao S: Effect of thiopental sodium on
N
-methyl-d-aspartate-gated currents. Can J
Anaesth 53:442–448, 2006.
194. Ge ZJ, Zhang LC, Zeng YM, et al: Involvement of
NMDA receptors in thiopental-induced loss of
righting reflex, antinociception and anticonvulsion
effects in mice. Pharmacology 80:127–133, 2007.
195. Fredriksson A, Ponten E, Gordh T, Eriksson P: Neo-
natal exposure to a combination of
N
-methyl-d-
aspartate and gamma-aminobutyric acid type A
receptor anesthetic agents potentiates apoptotic
neurodegeneration and persistent behavioral defi-
cits. Anesthesiology 107:427–436, 2007.
196. Judge S: Effect of general anaesthetics on synaptic
ion channels. Br J Anaesth 55:191–200, 1983.
197. Tanelian DL, Kosek P, Mody I, MacIver MB: The
role of the GABA
A
receptor/chloride channel
complex in anesthesia. Anesthesiology 78:757–776,
1993.
198. Michenfelder JD, Milde JH, Sundt TM Jr: Cerebral
protection by barbiturate anesthesia: Use after
middle cerebral artery occlusion in Java monkeys.
Arch Neurol 33:345–350, 1976.
199. Stullken EH Jr, Milde JH, Michenfelder JD, Tinker JH:
Thenonlinearresponsesof cerebralmetabolismto low
concentrations of halothane, enflurane, isoflurane,
and thiopental. Anesthesiology 46:28–34, 1977.
200. Baughman VL: Brain protection during neurosur-
gery. Anesthesiol Clin North Am 20:315–327,
2002.
201. Albrecht RF, Miletich DJ, Rosenberg R, Zahed B:
Cerebral blood flow and metabolic changes from
induction to onset of anesthesia with halothane or
pentobarbital. Anesthesiology 47:252–256, 1977.
202. Dundee J: Alterations in response to somatic pain
associated with anaesthesia, II: The effect of thio-
pentone and pentobarbitone. Br J Anaesth 32:407,
1960.
203. Pancrazio JJ, Frazer MJ, Lynch F.C. 3rd: Barbiturate
anestheticsdepresstherestingK+conductanceof myo-
cardium. J Pharmacol Exp Ther 265:358–365, 1993.
204. Brodie B, Kurz H, Schanker L: The importance of
dissociation constant and lipid-solubility in influen-
cing the passage of drugs into the cerebrospinal
fluid. J Pharmacol Exp Ther 130:22, 1960.
205. Mark L, Bruns J, Camponmanes C: The passage of
thiopental into brain. J Pharmacol Exp Ther 119:35,
1957.
206. Burch P, Stanski D: The role of metabolism and
protein binding in thiopental anesthesia. Anesthe-
siology 58:146, 1983.
207. Saidman L: Uptake, distribution and elimination of
barbiturates.
In
Eger E (ed): Anesthetic Uptake and
Action. Baltimore, Williams & Wilkins, 1974.
208. Stella L, Torri G, Castiglioni CL: The relative poten-
cies of thiopentone, ketamine, propanidid, alphaxa-
lone and diazepam: A statistical study in man. Br J
Anaesth 51:119–122, 1979.
209. Way W, Trevor A: Pharmacology of intravenous
nonnarcotic anesthetics. Miller RD (ed): Anesthe-
sia vol II, 2nd ed.New York, Churchill Livingstone,
1986.
210. Brodie B, Mark L, Papper E: The fate of thiopental
in man and method for its estimation in biological
material. J Pharmacol Exp Ther 98:85, 1950.
211. Homer TD, Stanski DR: The effect of increasing age
on thiopental disposition and anesthetic require-
ment. Anesthesiology 62:714–724, 1985.
212. Sorbo S, Hudson RJ, Loomis JC: The pharmacoki-
netics of thiopental in pediatric surgical patients.
Anesthesiology 61:666–670, 1984.
213. Korttila K, Ghoneim MM, Jacobs L, Lakes RS: Eva-
luation of instrumented force platform as a test to
measure residual effects of anesthetics. Anesthesio-
logy 55:625–630, 1981.
214. Todd MM, Drummond JC, U HS: The hemodyna-
mic consequences of high-dose thiopental anesthe-
sia. Anesth Analg 64:681–687, 1985.
215. Rodriguez E, Jordan R: Contemporary trends in
pediatric sedation and analgesia. Emerg Med Clin
North Am 20:199–222, 2002.
216. Kawar P, Dundee JW: Frequency of pain on injec-
tion and venous sequelae following the I.V. admi-
nistration of certain anaesthetics and sedatives. Br
J Anaesth 54:935–939, 1982.
217. Tarabadkar S, Kopriva D, Sreenivasan N, et al:
Hemodynamic impact of induction in patients with
decreased cardiac reserve. Anesthesiology 53:S43,
1980.
218. Seltzer J, Gerson J, Allen F: Comparison of the car-
diovascular effects of bolus IV: Incremental adminis-
tration of thiopentone. Br J Anaesth 52:527, 1980.
219. Eckstein J, Hamilton W, McCammond J: The effect
of thiopental on peripheral venous tone. Anesthe-
siology 22:525, 1961.
220. Kissin I, Motomura S, Aultman DF, Reves JG: Ino-
tropic and anesthetic potencies of etomidate and
thiopental in dogs. Anesth Analg 62:961–965, 1983.
221. Dennis SG, Wotton PR, Boswood A, Flaherty D:
Comparison of the effects of thiopentone and pro-
pofol on the electrocardiogram of dogs. Vet Rec
160:681–686, 2007.
222. Sonntag H, Hellberg K, Schenk HD, et al: Effects of
thiopental (Trapanal) on coronary blood flow and
myocardial metabolism in man. Acta Anaesthesiol
Scand 19:69–78, 1975.
223. Dundee J, Moore J: Thiopentone and methohexital:
A comparison as main anesthetic agents for a stan-
dard operation. Anaesthesia 16:50, 1961.
224. Gross JB, Zebrowski ME, Carel WD, et al: Time
course of ventilatory depression after thiopental
and midazolam in normal subjects and in patients
with chronic obstructive pulmonary disease. Anes-
thesiology 58:540–544, 1983.
225. Wyant G, Dobkin A, Aasheim G: Comparison of
seven intravenous anaesthetic agents in man. Br J
Anaesth 29:194, 1957.
226. Choi SD, Spaulding BC, Gross JB, Apfelbaum JL:
Comparison of the ventilatory effects of etomidate
and methohexital. Anesthesiology 62:442–447, 1985.
227. Wood M: Intravenous anesthetic agents. Drugs and
Anesthesia: Pharmacology for Anesthesiologists.
Baltimore, Williams & Wilkins, 1982.
228. Stovner J, Endresen R: Diazepam in intravenous
anesthesia. Lancet 2:1298–1299, 1965.
229. Walser A, Benjamin L, Flynn T: Quinazolines and
1, 4-benzodiazepines. 84: Synthesis and reactions of
imidazo (1,5)(1.4)-benzodiazepines. J Org Chem
43:936, 1978.
230. Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ:
Midazolam: Pharmacology and uses. Anesthesio-
logy 62:310–324, 1985.
231. Squires R,Braestrup C: Benzodiazepine receptors in
rat brain. Nature 266:732, 1977.
232. Greenblatt DJ, Shader RI, Abernethy DR: Drug
therapy: Current status of benzodiazepines. N Engl
J Med 309:354–358, 1983.
233. Arendt RM, Greenblatt DJ, deJong RH, et al: In
vitro correlates of benzodiazepine cerebrospinal
fluid uptake, pharmacodynamic action and peri-
pheral distribution. J Pharmacol Exp Ther 227:98–
106, 1983.
234. Klotz U, Reimann I: Elevation of steady-state diaze-
pam levels by cimetidine. Clin Pharmacol Ther
30:513–517, 1981.
528
Farmacología y anestesia
II